Abstract:Malignant melanoma is a type of skin cancer caused by mutations in the DNA of melanocytes. Melanoma is relatively rare compared with other types of skin tumors, but has a highly aggressive biological behavior and consequently, a poorer prognosis. Therefore, the present study aimed to explore the role and mechanism of Kruppel‑like factor 10 (KLF10) and acyl‑CoA medium‑chain synthetase 3 (ACSM3) in melanoma progression. KLF10 expression in melanoma tissues was predicted using Gene Expression Profiling Interactive Analysis (GEPIA). KLF10 expression in healthy and melanoma cells was also detected using reverse transcription‑quantitative PCR and western blotting. Cell transfection was performed to overexpress KLF10 or silence ACSM3. Cell viability, proliferation, migration, invasion and apoptosis were detected using Cell Counting Kit‑8, colony formation, wound healing, Transwell and TUNEL assays, respectively. The activity of the ACSM3 promoter was detected using a dual‑luciferase reporter assay, and the relationship between KLF10 and ACSM3 was detected using the GEPIA database and chromatin immunoprecipitation (ChIP). The results demonstrated that KLF10 expression was significantly downregulated in melanoma cells, especially in A375 cells. Compared with the Ov‑NC group, KLF10 overexpression significantly inhibited the proliferation, invasion and migration of melanoma cells and promoted their apoptosis. Similar to KLF10, ACSM3 was also downregulated in A375 cells compared with that in the HEM group, and the GEPIA database analysis and ChIP assay results demonstrated that KLF10 expression was positively associated with ACSM3 expression. Furthermore, silencing ACSM3 significantly reversed the effect of KLF10 overexpression on cell proliferation, invasion and migration, and ACSM3 knockdown increased the levels of phosphorylated (p)‑PI3K and p‑Akt compared with the levels in the Ov‑KLF10 + sh‑NC group. Overall, the present study suggested that KLF10 inhibited the proliferation, invasion and migration of melanoma cells by targeting ACSM3 via the PI3K/Akt signaling pathway.

Atypical contribution of caspase-3 to melanoma cancer cell motility by regulation of coronin 1B activity

Basal caspase-3 activity promotes migration, invasion, and vasculogenic mimicry formation of melanoma cells.

Caspase-3 promotes oncogene-induced malignant transformation via EndoG-dependent Src-STAT3 phosphorylation

Dependence of human cell survival and proliferation on the CASP3 prodomain

The Role of Caspase Family in Tumor Vasculogenic Mimicry

BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton

The Role of Caspases in Melanoma Pathogenesis

STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway

Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1

Caspase 3 May Participate in the Anti-Tumor Immunity of Dendritic Cells

Caspase 3 Expression Profiles in Meningioma Subtypes Based on Tissue Microarray Analysis

Caspase-3 Mediated Feedback Activation of Apical Caspases in Doxorubicin and TNF-α Induced Apoptosis

Caspase-3 Controls Aml1-Eto-Driven Leukemogenesis Via Autophagy Modulation In A Ulk1-Dependent Manner

Non-apoptotic activation of Drosophila caspase-2/9 modulates JNK signaling, the tumor microenvironment, and growth of wound-like tumors

Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients

A Systematic Pan-Cancer Analysis of CASP3 as a Potential Target for Immunotherapy

Caspase-3 over-expression is associated with poor overall survival and clinicopathological parameters in breast cancer: a meta-analysis of 3091 cases.

Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis

KLF10 upregulates ACSM3 via the PI3K/Akt signaling pathway to inhibit the malignant progression of melanoma

Caspases and Inhibitor of Apoptosis Proteins in Cutaneous and Mucosal Melanoma: Expression Profile and Clinicopathologic Significance

Dying Glioma Cells Establish a Proangiogenic Microenvironment Through a Caspase 3 Dependent Mechanism.